Cornerstone Capital, Inc. Acelrx Pharmaceuticals Inc Transaction History

Cornerstone Capital, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	BUY	$0.49 - $1.02 $39,200 - $81,600	80,000 New	80,000 $45,000
Q3 2021 Nov 09, 2021	SELL	$0.93 - $1.51 $15,763 - $25,594	-16,950 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$1.03 - $1.7 $5,871 - $9,690	-5,700 Reduced 25.17%	16,950 $23,000
Q1 2021 May 17, 2021	SELL	$1.25 - $2.77 $88,437 - $195,977	-70,750 Reduced 75.75%	22,650 $39,000
Q3 2020 Oct 27, 2020	BUY	$1.01 - $1.81 $5,050 - $9,050	5,000 Added 5.66%	93,400 $133,000
Q2 2020 Aug 14, 2020	BUY	$1.03 - $1.69 $1,699 - $2,788	1,650 Added 1.9%	88,400 $107,000
Q1 2020 May 15, 2020	SELL	$0.76 - $2.07 $307,655 - $837,956	-404,810 Reduced 82.35%	86,750 $102,000
Q4 2019 Feb 10, 2020	BUY	$1.66 - $2.4 $92,545 - $133,800	55,750 Added 12.79%	491,560 $1.04 Million
Q3 2019 Nov 13, 2019	BUY	$2.1 - $2.87 $108,045 - $147,661	51,450 Added 13.39%	435,810 $959,000
Q2 2019 Aug 14, 2019	BUY	$2.1 - $3.93 $686,301 - $1.28 Million	326,810 Added 567.87%	384,360 $972,000
Q1 2019 May 15, 2019	BUY	$2.35 - $3.83 $88,242 - $143,816	37,550 Added 187.75%	57,550 $200,000
Q4 2018 Feb 11, 2019	SELL	$2.13 - $4.8 $42,600 - $96,000	-20,000 Reduced 50.0%	20,000 $46,000
Q3 2018 Nov 13, 2018	BUY	$2.6 - $4.6 $104,000 - $184,000	40,000 New	40,000 $154,000
Q2 2018 Aug 13, 2018	SELL	$2.13 - $4.2 $85,200 - $168,000	-40,000 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$1.75 - $5.5 $70,000 - $220,000	40,000	40,000 $81,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Cornerstone Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Cornerstone Capital, Inc. with notifications on news.